Research Departments & Organizations
My research interest includes management of malignant hematology conditions such as acute leukemias (focus on treatment of older adults with AML, ALL as well as treatment of AML patients with FLT-3 inhibitors), myelodysplastic syndromes (MDS) and myeloprolipherative neoplasms (MPNs). I am currently serving as a Yale principle investigator for a number of clinical studies including industry-sponsored, cooperative group and investigator initiated trials (IITs) looking at the efficacy of different novel agents for patients with malignant hematological conditions who otherwise have very limited treatment options. I am working on IITs for patients with high risk myelofibrosis and accelerated/blast forms of MPNs. I participate in hematology group of Yale University Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center to study myeloid neoplasms epidemiology and outcomes with special interest in MPNs. I am involved in a number of retrospective projects looking at different aspects of management and outcomes among patients with AML and MDS using Yale myeloid malignancies database in collaboration with other institutions. As an associate program director of the hematology/oncology fellowship program I am interested in fellows’ career choices with respect to hematology with plans to participate in the national study with the support of American Society of Hematology (ASH) Committee on Training.